Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Gross Profit (2016 - 2025)

Historic Gross Profit for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $147.4 million.

  • Select Medical Holdings' Gross Profit rose 851.97% to $147.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $620.9 million, marking a year-over-year decrease of 301.56%. This contributed to the annual value of $633.6 million for FY2024, which is 1085.29% up from last year.
  • Latest data reveals that Select Medical Holdings reported Gross Profit of $147.4 million as of Q3 2025, which was up 851.97% from $155.4 million recorded in Q2 2025.
  • In the past 5 years, Select Medical Holdings' Gross Profit ranged from a high of $272.6 million in Q2 2021 and a low of -$159.2 million during Q4 2022
  • Over the past 5 years, Select Medical Holdings' median Gross Profit value was $157.2 million (recorded in 2021), while the average stood at $158.4 million.
  • As far as peak fluctuations go, Select Medical Holdings' Gross Profit tumbled by 20125.35% in 2022, and later surged by 19047.94% in 2023.
  • Select Medical Holdings' Gross Profit (Quarter) stood at $157.2 million in 2021, then tumbled by 201.25% to -$159.2 million in 2022, then surged by 190.48% to $144.1 million in 2023, then dropped by 4.57% to $137.5 million in 2024, then rose by 7.26% to $147.4 million in 2025.
  • Its last three reported values are $147.4 million in Q3 2025, $155.4 million for Q2 2025, and $180.6 million during Q1 2025.